How Much Does a Hematopoietic Stem Cell Transplant (Bone Marrow Transplant) Cost in 2026?

Hematopoietic stem cell transplant costs combine preconditioning chemotherapy, the transplant procedure itself, sterile-ward hospitalization, immunosuppressants, and donor testing, and the final figure is only confirmed through a hospital estimate — allogeneic transplants (using a donor's cells) cost more than autologous transplants (using the patient's own cells). That said, the only publicly fixed amount is the remote review fee of KRW 1,000,000.

Key Takeaways

• Hematopoietic stem cell transplant costs are divided into preconditioning chemotherapy, the transplant procedure, sterile-ward hospitalization, antibiotics and immunosuppressants, and — for donor-based cases — donor testing and collection costs, and these are confirmed only through a hospital estimate.
• Allogeneic transplants (using a donor's cells) involve greater cost and management burden than autologous transplants (using the patient's own cells).
• The remote review (pre-arrival review) fee is KRW 1,000,000, and if you sign a treatment contract after this review, that amount is deducted from your treatment costs.
• Total stay is usually 6–8 weeks, including 3–6 weeks of hospitalization; allogeneic transplants may require longer follow-up, extending to around 100 days post-transplant.
• Engraftment — when the new cells settle in and begin producing blood — usually takes 2–4 weeks, during which infection risk is high and patients remain in a sterile ward.

Why can't hematopoietic stem cell transplant costs be given as a single figure?

• Hematopoietic stem cell transplants vary in cost components depending on disease subtype, whether the transplant is autologous or allogeneic, the donor search process, and length of hospitalization, so no single fixed amount can be quoted.
• Costs consist of preconditioning high-dose chemotherapy, the transplant procedure (cell infusion), sterile-ward hospitalization fees, antibiotics and immunosuppressants, and — for allogeneic transplants — donor histocompatibility testing and cell collection costs.
• Allogeneic transplants cost more than autologous transplants, because the donor testing/collection process and the period of immunosuppressant use for managing graft-versus-host disease are longer.
• All of these amounts are finalized only through the hospital's written estimate, and the only figure we can disclose as confirmed is the remote review fee of KRW 1,000,000. If you sign a treatment contract after the remote review, this amount is deducted from your treatment costs.

What is the order of the treatment process?

• Stage 1: Over the first 1–2 weeks after arrival, staging tests, heart/lung/liver/kidney function tests, and infection screening are conducted; for allogeneic transplants, donor histocompatibility and health screening are done in parallel.
• Stage 2: Preconditioning chemotherapy is given for about 1 week to clear out the diseased bone marrow.
• Stage 3: On the scheduled day, hematopoietic stem cells are infused intravenously. The infusion itself takes only tens of minutes and resembles a transfusion rather than surgery.
• Stage 4: The patient spends 2–4 weeks in a sterile ward until engraftment is confirmed; fever, mouth sores, and low blood counts are common during this period and are managed with transfusions and antibiotics.
• Stage 5: Once engraftment is confirmed and the patient's condition is stable, they are discharged — but do not return home immediately, instead staying within walking distance of the hospital for frequent outpatient visits. For allogeneic transplants, close monitoring for around 100 days post-transplant is often the standard.

How should I prepare for length of stay and accompanying family?

• It is common to plan for 3–6 weeks of hospitalization and 6–8 weeks total stay, with allogeneic transplants potentially requiring longer.
• If the stay exceeds 90 days, a long-term treatment visa (G-1-10) is arranged for the patient and accompanying family; short-term treatment of 90 days or less falls under the medical tourism visa (C-3-3). Visa issuance and review periods are determined by the relevant overseas diplomatic mission.
• Accompanying family members typically stay at a residence within walking distance of the hospital; sterile wards restrict the number of visitors, visiting hours, and items brought in, and an interpreter will explain these rules together with you.
• The return-home timing is often set at 2–3 weeks after discharge for autologous transplants, and around 100 days post-transplant for allogeneic transplants, though the final decision rests with the attending medical team.

FAQ — What if there is no donor available?

Donors are sought in the following order: siblings, haploidentical donors (parent or child, a half-match), unrelated donors, and cord blood. Korea has accumulated extensive experience in hematopoietic stem cell transplantation and haploidentical transplants, so even without a fully matched sibling, other options can be considered. Which path is feasible depends on the type of disease, the patient's age, and urgency.

FAQ — Does graft-versus-host disease affect cost and duration?

Graft-versus-host disease (GVHD) is a reaction in allogeneic transplants where the donor's immune cells attack the patient's body, which can present as skin rash, diarrhea, elevated liver enzymes, or dryness of the eyes and mouth. Immunosuppressants are used to prevent this, and if this management period lengthens, it can affect both the length of stay and cost items. Severity ranges widely from mild to severe, making early detection and control important.

Sources and Notes

• This article was written based on notes on hematopoietic stem cell transplantation, hematologic cancer, and medical visas (National Cancer Center Korea, NCCN patient guidelines, HiKorea, Ministry of Health and Welfare, Medical Korea).
• This content is intended to provide general medical information, and actual diagnosis, treatment methods, and outcomes may vary depending on the individual's condition. Please be sure to consult with your medical team to determine an accurate diagnosis and treatment plan.